8:50am ET
Investing
Top Analyst Upgrades and Downgrades: Altria, BofA, FireEye, Ford, J.P. Morgan, Linn Energy and More
These are the top analyst upgrades and downgrades covered by 24/7 Wall St. for Monday, September 8, 2014.
Companies
Keryx Biopharmaceuticals
$3.36
▼ $0.07 (−2.04%) today
Markets closed · 9:04pm ET
KERX Coverage
Page 23:05pm ET
Health and Healthcare
Keryx Finds Out That Not All FDA Approvals Are Great Wins
ThinkstockKeryx Biopharmaceuticals Inc. (NASDAQ: KERX) announced on Friday that it had received approval from the FDA on its most recent drug Ferric Citrate, formerly known as Zerenex. The drug is designed to…
Chris Lange 8:55am ET
Investing
Russell 2000 Rebalance May Bring Huge Buying in Key Stocks
The Quantitative Strategies team at Jefferies closely monitors the index changes. 24/7 Wall St. screened the Jefferies list of stocks that will see major position adds for the rebalance. Some of them…
8:25am ET
Health and Healthcare
Oppenheimer Sees Five Biotech Stocks to Buy With Potential 50% Upside, or More
The team at Oppenheimer has a list of biotech stocks to buy that feature catalysts that could be game changers. They all have 50% or higher upside to the firm's price target.
1:10pm ET
Health and Healthcare
Four Big Healthy Biotech Gainers, One Big Loser
ThinkstockBiotech and certain aspects of the health care and life sciences sector can often see incredible surges from day to day. The group can also witness many implosions on bad news as…
8:05am ET
Investing
Top Analyst Upgrades and Stocks to Buy: Adobe, Gevo, Keryx, Teva and More
Investors and traders are often on the hunt for fresh research ideas that will lead to higher income or more profits in this choppy stock and volatile market. 24/7 Wall St. reviews…
8:10am ET
Health and Healthcare
PropThink Biotech Stocks With Big Upside Potential
ThinkstockThe world of biotech investing is always a difficult one. Often a binary event, such as a U.S. Food and Drug Administration (FDA) approval or a life-saving capital raise is the difference…
6:50am ET
Banking, finance, and taxes
Thirteen Stocks Expected to Rise 40% to 100% — or More
Investors and traders alike always seem to be on the lookout for new speculative investment ideas that can generate massive long-term or short-term gains. While investors get to see many Buy ratings…
8:40am ET
Health and Healthcare
PropThink Analyst Finds Five Cheap Biotech Stocks to Buy
ThinkstockBiotech investing has always proven to be a slippery slope. It is one thing to own one of the large-cap biotech stocks, but it can be a challenge when looking for the stocks…
4:08pm ET
Investing
24/7 Wall St. Closing Bell — February 1, 2013: Markets Stronger on Economic Data (VZ, MA, EPD, STZ, UPS, BYI, GDOT, WYNN, CVX, XOM, MAT, MRK, NOV, TSN, CYOU, GCI, HUM, GOLD, RCL, SPG, CLX, ZTS, KERX, FB)
U.S. equity markets opened higher this morning on the heels of a solid report on U.S. nonfarm payrolls, which rose less than expected but on top of a large upward revision for…
4:06pm ET
Investing
24/7 Wall St. Closing Bell — January 29, 2013: Markets Shake Off Slow Start, Post Gains (STX, TSN, SBUX, ANF, CAT, YHOO, STX, STLD, BSX, DHI, F, BTU, PFE, VLO, AMZN, BRCM, RYL, RHI, ADT, LLL, PSX, NOC, SO, KERX, VMW, OCZ)
U.S. equity markets opened slightly lower this morning following not-much in the way of new data and a wait-and-see attitude until tomorrow’s meeting announcement from the FOMC, which began a two-day meeting…
11:04am ET
Investing
Today’s Market Winners and Losers
Photo by Spencer Platt/Getty ImagesThe stock market is mixed Tuesday, with the Dow Jones Industrial Average up 0.27%, the Nasdaq down 0.35% and the S&P 500 up 0.13%. Today’s winners are a biopharmaceutical…
4:05pm ET
Investing
24/7 Wall St. Closing Bell — January 28, 2013: Markets Open Mixed, Close Nearly Flat (AKS, HEP, NWSA, FB, BBY, CAT, ROP, SIFY, BIIB, YHOO, STX, VMW, STLD, BSX, DHI, F, BTU, PFE, VLO, KERX, JOSB, HLF)
U.S. equity markets opened mixed this morning on relatively little new data. In Europe, Italian consumer confidence rose more than expected and Germany auctioned 12-month bills at a positive yield for the…
1:56pm ET
Health and Healthcare
Keryx Gets Back on the Map
ThinkstockKeryx Biopharmaceuticals Inc. (NASDAQ: KERX) has not been a household name in biotech investing, but the move on news on Monday has put the company on the map. After shares are up…
Jon C. Ogg 10:23am ET
Investing
Today’s Market Winners and Losers
The stock market is down Monday, with the Dow Jones Industrial Average down 0.20%, the Nasdaq down 0.04% and the S&P 500 down 0.39%. Today’s sole winner is a pharmaceutical company with a…
247sam